Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

1.69USD
19 Oct 2018
Change (% chg)

$-0.05 (-2.87%)
Prev Close
$1.74
Open
$1.75
Day's High
$1.76
Day's Low
$1.69
Volume
25,925
Avg. Vol
38,584
52-wk High
$4.56
52-wk Low
$1.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.09 -0.041
Mar '18 0.15 -0.047
FY 2017 Dec '17 0.11 -0.060
Sep '17 0.03 -0.086
Jun '17 0.01 -0.052
Mar '17 0.08 -0.057
FY 2016 Dec '16 0.04 -0.059
Sep '16 0.05 -0.067
Jun '16 0.15 -0.084
Mar '16 0.04 -0.076
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta 0.85 0.93 0.88
Price to Sales (TTM) 1,110.25 124.37 5.83
Price to Book (MRQ) -- 15.29 4.89
Price to Tangible Book (MRQ) -- 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 5.90 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -93.70 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago -42.39 103.65 5.80
Sales - 5 Yr. Growth Rate -38.07 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.65 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago 55.50 -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -39.54 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.94 1.95 2.25
Current Ratio (MRQ) 0.94 5.36 3.05
LT Debt to Equity (MRQ) -- 34.93 12.76
Total Debt to Equity (MRQ) -- 36.74 17.18
Interest Coverage (TTM) -88.90 -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 15.24 40.09 54.87
Gross Margin - 5 Yr. Avg. 89.96 49.02 52.39
EBITD Margin (TTM) -6,209.52 -- --
EBITD - 5 Yr. Avg -383.86 -579.09 11.01
Operating Margin (TTM) -6,210.97 -786.66 4.07
Operating Margin - 5 Yr. Avg. -384.15 -600.20 6.34
Pre-Tax Margin (TTM) -6,370.48 -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -387.78 -605.79 6.78
Net Profit Margin (TTM) -6,370.48 -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -387.36 -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,045 22,677,535 808,218,600
Net Income/Employee (TTM) -2,869,585 1,703,754 95,058,584
Receivable Turnover (TTM) 12.23 20.77 5.78
Inventory Turnover (TTM) 8.87 2.37 3.63
Asset Turnover (TTM) 0.21 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1,329.05 -1.39 10.90
Return on Assets - 5 Yr. Avg. -530.60 3.03 12.01
Return on Investment (TTM) -- 0.21 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -- 1.17 15.99
Return on Equity - 5 Yr. Avg. -- 2.74 16.87
  1 Year 3 Year 5 Year
Sales % -89.73 -56.13 -38.07
EPS (TTM) % 40.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nymox Pharmaceutical Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.23%
# of Holders: 78
Total Shares Held: 4,127,330
3 Mo. Net Change: -85,591
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 1
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.